JPH04500602A - 合成hivプロテアーゼ遺伝子およびその発現法 - Google Patents
合成hivプロテアーゼ遺伝子およびその発現法Info
- Publication number
- JPH04500602A JPH04500602A JP1508775A JP50877589A JPH04500602A JP H04500602 A JPH04500602 A JP H04500602A JP 1508775 A JP1508775 A JP 1508775A JP 50877589 A JP50877589 A JP 50877589A JP H04500602 A JPH04500602 A JP H04500602A
- Authority
- JP
- Japan
- Prior art keywords
- protease
- gene
- hiv
- synthetic
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
- C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21830488A | 1988-07-13 | 1988-07-13 | |
| US218,304 | 1988-07-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH04500602A true JPH04500602A (ja) | 1992-02-06 |
Family
ID=22814563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1508775A Pending JPH04500602A (ja) | 1988-07-13 | 1989-07-13 | 合成hivプロテアーゼ遺伝子およびその発現法 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0425580A4 (fr) |
| JP (1) | JPH04500602A (fr) |
| AU (1) | AU635216B2 (fr) |
| CA (1) | CA1340748C (fr) |
| IL (1) | IL90947A (fr) |
| WO (1) | WO1990000556A1 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5599789A (en) * | 1991-12-24 | 1997-02-04 | Amrad Corporation Limited | Method for the treatment of tumours and sarcomas |
| US6071895A (en) * | 1992-03-11 | 2000-06-06 | Narhex Limited | Polar-substituted hydrocarbons |
| MXPA93002392A (es) | 1992-03-11 | 2005-02-04 | Narhex Ltd | Derivados amino de hidrocarburos-oxo e hidroxi-substituidos. |
| JPH07504654A (ja) * | 1992-03-11 | 1995-05-25 | ナルヘックス リミテッド | オキソ及びヒドロキシ置換炭化水素のアミン誘導体 |
| US5888992A (en) * | 1992-03-11 | 1999-03-30 | Narhex Limited | Polar substituted hydrocarbons |
| US6001558A (en) * | 1997-06-25 | 1999-12-14 | Ortho Clinical Diagnostics, Inc. | Amplification and detection of HIV-1 and/or HIV 2 |
| JP4776075B2 (ja) | 1998-12-31 | 2011-09-21 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | 改変hivenvポリペプチド |
| US7935805B1 (en) | 1998-12-31 | 2011-05-03 | Novartis Vaccines & Diagnostics, Inc | Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
| AU2487300A (en) | 1998-12-31 | 2000-07-31 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| AU2221600A (en) | 1998-12-31 | 2000-07-31 | Chiron Corporation | Improved expression of hiv polypeptides and production of virus-like particles |
| CA2458995C (fr) | 2001-08-31 | 2013-04-30 | Chiron Corporation | Polynucleotides codant des polypeptides de type b du vih antigeniques, polypeptides et leurs utilisations |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5252477A (en) * | 1987-06-01 | 1993-10-12 | The United States Of America As Represented By The United States Department Of Health And Human Services | Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation |
-
1989
- 1989-07-06 CA CA000604978A patent/CA1340748C/fr not_active Expired - Lifetime
- 1989-07-12 IL IL90947A patent/IL90947A/xx active IP Right Grant
- 1989-07-13 AU AU40585/89A patent/AU635216B2/en not_active Expired
- 1989-07-13 JP JP1508775A patent/JPH04500602A/ja active Pending
- 1989-07-13 WO PCT/US1989/002996 patent/WO1990000556A1/fr not_active Ceased
- 1989-07-13 EP EP19890909316 patent/EP0425580A4/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| PRO.NATL.ACAD.SCI=1987US * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA1340748C (fr) | 1999-09-14 |
| WO1990000556A1 (fr) | 1990-01-25 |
| EP0425580A1 (fr) | 1991-05-08 |
| AU4058589A (en) | 1990-02-05 |
| IL90947A0 (en) | 1990-02-09 |
| AU635216B2 (en) | 1993-03-18 |
| EP0425580A4 (en) | 1992-05-06 |
| IL90947A (en) | 1997-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nicklin et al. | Poliovirus proteinase 3C: large-scale expression, purification, and specific cleavage activity on natural and synthetic substrates in vitro | |
| Liebig et al. | Purification of two picornaviral 2A proteinases: Interaction with eIF-4. gamma. and influence on the in vitro translation | |
| Talanian et al. | Sequence-specific DNA binding by a short peptide dimer | |
| Gentz et al. | Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis. | |
| Calnan et al. | Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition. | |
| Sauer et al. | Primary structure of the λ repressor | |
| SU1644720A3 (ru) | Способ получени антигенной детерминанты вируса СПИД | |
| Toma et al. | Grafting of a calcium-binding loop of thermolysin to Bacillus subtilis neutral protease | |
| Smith et al. | Purification and characterization of an active human immunodeficiency virus type 1 RNase H domain | |
| Swingler et al. | The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix | |
| DiIanni et al. | Characterization of an active single polypeptide form of the human immunodeficiency virus type 1 protease. | |
| Preusser et al. | Direct in vitro binding of full-length human immunodeficiency virus type 1 Nef protein to CD4 cytoplasmic domain | |
| JPS62500633A (ja) | タンパク質結合酵素相補性検定に関する方法 | |
| JP2006518983A (ja) | 改変された特異性を有するプロテアーゼを作製する方法およびスクリーニングする方法 | |
| JPH04500602A (ja) | 合成hivプロテアーゼ遺伝子およびその発現法 | |
| Rea et al. | Crystal structure of Porphyromonas gingivalis dipeptidyl peptidase 4 and structure-activity relationships based on inhibitor profiling | |
| BLAIR et al. | Mutations in the poliovirus 3CD proteinase S1-specificity pocket affect substrate recognition and RNA binding | |
| Louis et al. | Chemical synthesis and expression of the HIV-1 protease gene in E. coli | |
| Libby et al. | Human rhinovirus 3C protease: cloning and expression of an active form in Escherichia coli | |
| Tomasselli et al. | Calcium‐free calmodulin is a substrate of proteases from human immunodeficiency viruses 1 and 2 | |
| Tomasselli et al. | Interdomain hydrolysis of a truncated Pseudomonas exotoxin by the human immunodeficiency virus-1 protease. | |
| Fan et al. | The differential processing of homodimers of reverse transcriptases from human immunodeficiency viruses type 1 and 2 is a consequence of the distinct specificities of the viral proteases | |
| Rumlová et al. | Specific in vitro cleavage of Mason–Pfizer monkey virus capsid protein: evidence for a potential role of retroviral protease in early stages of infection | |
| CN113521286B (zh) | 冠状病毒蛋白酶抑制剂及其应用 | |
| Dash et al. | Interactions of a novel inhibitor from an ExtremophilicBacillus sp. with HIV-1 protease: IMPLICATIONS FOR THE MECHANISM OF INACTIVATION |